Further to intimation dated November 29, 2025, regarding the approval of sub-division / split of equity shares by the Board of Directors of the Company, Titan Biotech has informed that pursuant to Regulation 42 of the Listing Regulations, the Company has fixed Friday, February 20, 2026, as the Record Date for the purpose of determining the eligibility of Members for the sub-division / Split of 1 equity share of face value of Rs 10 each, fully paid-up, into 5 equity shares of face value of Rs 2 each, fully paid-up as approved by the Members of the Company through Postal Ballot on December 30, 2025.
The above information is a part of company’s filings submitted to BSE.
